H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 11.7% of adults in New Haven have diagnosed diabetes — 0.3 points below the U.S. 12% figure. Census population 134,023. Connecticut Medicare wound biologics: National Government Services (NGS) (JK). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed New Haven clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a New Haven storefront.
Skin Substitute Therapy Products in New Haven, CT for clinics & physicians. Skin substitute therapy for co… Compliance support & pricing — contact Hawk Medical.
Adult arthritis here is 20.3% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. CDC PLACES (2023, crude) estimates 11.7% of adults in New Haven have diagnosed diabetes — 0.3 points below the U.S. 12% figure. Together those PLACES numbers are why a city under 250k still needs separate PRP and CTP protocols. skin substitute therapy inventory is national; utilization is JK-local.
National Skin Substitute Therapy Products notes (how the product actually works)JK reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in New Haven is 11.7% or not. PLACES is planning data. The LCD is the claim.
Vendor consolidation is boring on purpose: one account, IFUs filed, JK articles mapped. 14.7% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 11.7% of adults — 0.3 points below the U.S. 12% figure. Obesity is 37.9%; arthritis is 20.3%. That is place-level BRFSS modeling, not a clinic census and not a New Haven trial.
Connecticut is not in CDC’s core Diabetes Belt list, but 12% national prevalence still means diabetic wounds will appear. Stock from your clinic mix, not from belt branding.
Yes. Tissue products come from FDA-registered banks with donor screening and lot traceability. Your receiving SOP should file IFU, lot, and indication with the chart. That packet is what JK reviewers and surveyors expect — not a brochure.
We do not publish a consumer directory of every account. Patients should ask their current specialist whether the practice offers skin substitute therapy products and which products they use.
Ask for the IFU, the lot-traceability packet, and the National Government Services (NGS) article IDs for the codes you actually bill. If the sales sheet cannot produce those, do not put it in a New Haven fridge. That is how an account with us starts.
Contact us to learn how Hawk Medical supports practices in New Haven, CT.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for New Haven is JK geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for New Haven — 0.3 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Connecticut Part B wound biologics follow this contractor (siblings: MA, ME, NH, NY, RI, VT). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in New Haven. Useful for joint-program math; still needs a diagnosis and privileging.
No New Haven storefront. Joe Bradley is an active practice owner. skin substitute therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.